These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 10686645

  • 1. [Transfusion of platelet concentrates].
    Rieux C, Lee K, Lavaud A, Bierling P.
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [Abstract] [Full Text] [Related]

  • 2. [Transfusion of platelet concentrates].
    Bierling P.
    Transfus Clin Biol; 2009 May; 16(2):190-4. PubMed ID: 19443251
    [Abstract] [Full Text] [Related]

  • 3. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L, Woodfield DG.
    N Z Med J; 1984 Oct 24; 97(766):719-21. PubMed ID: 6595558
    [Abstract] [Full Text] [Related]

  • 4. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
    Amemiya Y.
    Nihon Rinsho; 1997 Sep 24; 55(9):2392-8. PubMed ID: 9301306
    [Abstract] [Full Text] [Related]

  • 5. Platelet transfusion refractoriness.
    Hod E, Schwartz J.
    Br J Haematol; 2008 Jul 24; 142(3):348-60. PubMed ID: 18510692
    [Abstract] [Full Text] [Related]

  • 6. Optimizing platelet transfusion therapy.
    Heal JM, Blumberg N.
    Blood Rev; 2004 Sep 24; 18(3):149-65. PubMed ID: 15183900
    [Abstract] [Full Text] [Related]

  • 7. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J, Bronfman L, Bertín P, Marzouka E, Hidalgo P, Amaya S, Mezzano D.
    Rev Med Chil; 1997 Nov 24; 125(11):1305-12. PubMed ID: 9609051
    [Abstract] [Full Text] [Related]

  • 8. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.
    Wong M, Narra R, Selim M, Zimmerman MA, Kim J, Padmanabhan A, Hong JC.
    J Surg Res; 2020 Nov 24; 255():99-105. PubMed ID: 32543385
    [Abstract] [Full Text] [Related]

  • 9. [Transfusion-refractory thrombocytopenia during chemotherapy: pathogenesis, frequency and treatment].
    Helleberg C, Taaning EB, Johnsen HE.
    Ugeskr Laeger; 1995 Sep 11; 157(37):5082-6. PubMed ID: 7502374
    [Abstract] [Full Text] [Related]

  • 10. [Refractoriness to platelet transfusion].
    Tsurumi H, Hara T, Moriwaki H.
    Ryoikibetsu Shokogun Shirizu; 1998 Sep 11; (21 Pt 2):332-4. PubMed ID: 9833505
    [No Abstract] [Full Text] [Related]

  • 11. [Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter].
    Handa M, Ikeda Y, Kurata Y, Tsubaki K, Horiuchi A, Furihata K, Kimura Y, Toyama K, Takamoto S, Tsukimoto I.
    Rinsho Ketsueki; 1992 Apr 11; 33(4):451-60. PubMed ID: 1602608
    [Abstract] [Full Text] [Related]

  • 12. Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness.
    Saris A, Pavenski K.
    Transfus Med Rev; 2020 Oct 11; 34(4):250-257. PubMed ID: 33127210
    [Abstract] [Full Text] [Related]

  • 13. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
    Benson K, Fields K, Hiemenz J, Zorsky P, Ballester O, Perkins J, Elfenbein G.
    Semin Oncol; 1993 Oct 11; 20(5 Suppl 6):102-9. PubMed ID: 8211211
    [Abstract] [Full Text] [Related]

  • 14. Anti-HLA alloantibodies in surgical patients refractory to platelet transfusion.
    Peña JR, Saidman SL, Girouard TC, Meister E, Dzik WH, Makar RS.
    Am J Hematol; 2014 Sep 11; 89(9):E133-7. PubMed ID: 24816643
    [Abstract] [Full Text] [Related]

  • 15. Management of patients refractory to platelet transfusion.
    Chockalingam P, Sacher RA.
    J Infus Nurs; 2007 Sep 11; 30(4):220-5. PubMed ID: 17667077
    [Abstract] [Full Text] [Related]

  • 16. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
    Basire A, Picard C.
    Transfus Clin Biol; 2014 Nov 11; 21(4-5):193-206. PubMed ID: 25277423
    [Abstract] [Full Text] [Related]

  • 17. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA, Choo SY, Little JA.
    Bone Marrow Transplant; 2000 Aug 11; 26(3):315-20. PubMed ID: 10967572
    [Abstract] [Full Text] [Related]

  • 18. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
    Bajpai M, Kaura B, Marwaha N, Kumari S, Sharma RR, Agnihotri SK.
    Natl Med J India; 2005 Aug 11; 18(3):134-6. PubMed ID: 16130614
    [Abstract] [Full Text] [Related]

  • 19. [The effect of HLA alloimmunization and other factors on the effectiveness of thrombocyte concentrates].
    Pittrová H, Koza V, Cepelák V, Bufková D.
    Cas Lek Cesk; 1990 Jun 15; 129(24):751-3. PubMed ID: 2393882
    [Abstract] [Full Text] [Related]

  • 20. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duqesnoy RJ.
    Prog Clin Biol Res; 1978 Jun 15; 28():229-43. PubMed ID: 88057
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.